Innovative technologies Push the boundaries of immunotherapy Transgene combines cutting-edge technologies, a multidisciplinary team and a prestigious international network. Discover our two therapeutic approaches Discover our technologies
Category: Tools-Home-cartouches
TG4001 box
TG4001 A therapeutic vaccine in Phase II TG4001 targets HPV-induced anogenital cancers. More information
myvac-box
One patient, one cancer, one vaccine With myvac®, Transgene enters the field of individualized immunotherapies with a unique virus-based immunotherapy platform. myvac® video Discover myvac® Watch Alessandro Riva presenting first clinical benefits of neoantigen cancer vaccine, TG4050, in head & neck cancer at AACR 2024
invirio-box
A new generation of products These innovative multifunctional OVs are able to modulate the tumor micro-environment to better attack cancer. invir.IO® en image Discover invir.IO®